H. J. Ehrlich

676 total citations
14 papers, 555 citations indexed

About

H. J. Ehrlich is a scholar working on Hematology, Cancer Research and Genetics. According to data from OpenAlex, H. J. Ehrlich has authored 14 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 5 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in H. J. Ehrlich's work include Platelet Disorders and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Protease and Inhibitor Mechanisms (5 papers). H. J. Ehrlich is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Protease and Inhibitor Mechanisms (5 papers). H. J. Ehrlich collaborates with scholars based in Austria, United States and Germany. H. J. Ehrlich's co-authors include M Linders, Jaap Keijer, Hans Pannekoek, Raymond Klein Gebbink, Klaus T. Preissner, Nils U. Bang, I. Scharrer, S. Richard Jaskunas, S. Betty Yan and Brian W. Grinnell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

H. J. Ehrlich

14 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. J. Ehrlich Austria	11	423	233	123	93	63	14	555
Senichiro Hashimoto Japan	10	305 0.7×	101 0.4×	68 0.6×	94 1.0×	55 0.9×	15	422
M Linders Netherlands	8	317 0.7×	357 1.5×	134 1.1×	60 0.6×	67 1.1×	9	482
Jaron Lockett United States	6	84 0.2×	155 0.7×	149 1.2×	42 0.5×	33 0.5×	7	367
M Tweeddale Canada	7	188 0.4×	66 0.3×	120 1.0×	85 0.9×	45 0.7×	8	399
R. Picone Italy	5	221 0.5×	327 1.4×	160 1.3×	44 0.5×	20 0.3×	8	466
Alec Ritchie United States	10	174 0.4×	32 0.1×	131 1.1×	43 0.5×	44 0.7×	14	429
K Muraoka Japan	6	160 0.4×	42 0.2×	189 1.5×	52 0.6×	16 0.3×	12	453
N Aoki Japan	10	233 0.6×	52 0.2×	173 1.4×	84 0.9×	34 0.5×	12	446
Aurelia Lamanuzzi Italy	14	230 0.5×	120 0.5×	309 2.5×	27 0.3×	24 0.4×	19	478
Egbert J.A. Gerritsen Netherlands	7	48 0.1×	69 0.3×	251 2.0×	71 0.8×	41 0.7×	8	390

Countries citing papers authored by H. J. Ehrlich

Since Specialization

Citations

This map shows the geographic impact of H. J. Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. J. Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. J. Ehrlich more than expected).

Fields of papers citing papers by H. J. Ehrlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. J. Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. J. Ehrlich. The network helps show where H. J. Ehrlich may publish in the future.

Co-authorship network of co-authors of H. J. Ehrlich

This figure shows the co-authorship network connecting the top 25 collaborators of H. J. Ehrlich. A scholar is included among the top collaborators of H. J. Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. J. Ehrlich. H. J. Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Turecek, Peter L., M.J. Bossard, Michael Graninger, et al.. (2012). BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.. PubMed. 32 Suppl 1. S29–38. 86 indexed citations

Björkander, Janne, J Nikoskelainen, Heinz Leibl, et al.. (2006). Prospective open‐label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo‐ or agammaglobulinemia. Vox Sanguinis. 90(4). 286–293. 40 indexed citations

Nemes, László, Toshko Lissitchkov, Anna Klukowska, et al.. (2006). Evaluation of pharmacokinetics, efficacy and safety of Immunate^® solvent detergent in previously treated patients with severe haemophilia A. Haemophilia. 13(1). 9–11. 10 indexed citations

Schwarz, H. P., et al.. (2004). Anti-Fas antibodies in IVIG products and in healthy blood donors. Journal of Allergy and Clinical Immunology. 113(2). S213–S213. 1 indexed citations

Scharrer, I. & H. J. Ehrlich. (2001). Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII. Haemophilia. 7(4). 346–348. 24 indexed citations

Scharrer, I. & H. J. Ehrlich. (2001). Lack of evidence for increased inhibitor incidence in patients switched from plasma‐derived to recombinant factor VIII. Haemophilia. 7(4). 346–348. 10 indexed citations

Keijer, Jaap, et al.. (1991). The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance. Blood. 78(2). 401–409. 85 indexed citations

Ehrlich, H. J., Brian W. Grinnell, S. Richard Jaskunas, et al.. (1990). Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.. The EMBO Journal. 9(8). 2367–2373. 41 indexed citations

Ehrlich, H. J., N L Esmon, & Nils U. Bang. (1990). In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits.. PubMed. 115(2). 182–9. 8 indexed citations

10.

Keijer, Jaap, M Linders, H. J. Ehrlich, Raymond Klein Gebbink, & Hans Pannekoek. (1990). Stabilisation of plasminogen activator inhibitor type 1 (PAI-1) activity by arginine: Possible implications for the interaction of PAI-1 with vitronectin. Fibrinolysis and Proteolysis. 4(3). 153–159. 17 indexed citations

11.

Ehrlich, H. J., Raymond Klein Gebbink, Jaap Keijer, et al.. (1990). Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.. Journal of Biological Chemistry. 265(22). 13029–13035. 142 indexed citations

12.

Ehrlich, H. J., S. Richard Jaskunas, Brian W. Grinnell, S. Betty Yan, & Nils U. Bang. (1989). Direct Expression of Recombinant Activated Human Protein C, a Serine Protease. Journal of Biological Chemistry. 264(24). 14298–14304. 22 indexed citations

13.

Ehrlich, H. J., Nils U. Bang, Sharon Little, et al.. (1987). Biological properties of a kringleless tissue plasminogen activator (t-PA) mutant. Fibrinolysis and Proteolysis. 1(2). 75–81. 33 indexed citations

14.

Suttie, John W., JoAnn Hoskins, H. J. Ehrlich, et al.. (1987). Vitamin K-dependent carboxylase: possible role of the substrate "propeptide" as an intracellular recognition site.. Proceedings of the National Academy of Sciences. 84(3). 634–637. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact